BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 32167866)

  • 1. Prospective Evaluation of Focal High Intensity Focused Ultrasound for Localized Prostate Cancer.
    Nahar B; Bhat A; Reis IM; Soodana-Prakash N; Becerra MF; Lopategui D; Venkatramani V; Patel R; Madhusoodanan V; Kryvenko ON; Ritch CR; Gonzalgo ML; Punnen S; Parekh DJ
    J Urol; 2020 Sep; 204(3):483-489. PubMed ID: 32167866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective Multicenter Phase II Study on Focal Therapy (Hemiablation) of the Prostate with High Intensity Focused Ultrasound.
    Ganzer R; Hadaschik B; Pahernik S; Koch D; Baumunk D; Kuru T; Heidenreich A; Stolzenburg JU; Schostak M; Blana A
    J Urol; 2018 Apr; 199(4):983-989. PubMed ID: 29107031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer treatment by the latest focal HIFU device with MRI/TRUS-fusion control biopsies: A prospective evaluation.
    von Hardenberg J; Westhoff N; Baumunk D; Hausmann D; Martini T; Marx A; Porubsky S; Schostak M; Michel MS; Ritter M
    Urol Oncol; 2018 Sep; 36(9):401.e1-401.e9. PubMed ID: 30093211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal Therapy for Prostate Cancer with In-Bore MR-guided Focused Ultrasound: Two-Year Follow-up of a Phase I Trial-Complications and Functional Outcomes.
    Tay KJ; Cheng CWS; Lau WKO; Khoo J; Thng CH; Kwek JW
    Radiology; 2017 Nov; 285(2):620-628. PubMed ID: 28654336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensive Histological Sampling following Focal Therapy of Clinically Significant Prostate Cancer with High Intensity Focused Ultrasound.
    Mortezavi A; Krauter J; Gu A; Sonderer J; Bruhin J; Reeve KA; Held L; Donati OF; Rupp NJ; Moch H; Sulser T; Eberli D
    J Urol; 2019 Oct; 202(4):717-724. PubMed ID: 31042109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years.
    Thüroff S; Chaussy C
    J Urol; 2013 Aug; 190(2):702-10. PubMed ID: 23415962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II Evaluation of Magnetic Resonance Imaging Guided Focal Laser Ablation of Prostate Cancer.
    Eggener SE; Yousuf A; Watson S; Wang S; Oto A
    J Urol; 2016 Dec; 196(6):1670-1675. PubMed ID: 27449263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urethra-sparing high-intensity focused ultrasound for localized prostate cancer: Functional and oncological outcomes.
    Shoji S; Nakano M; Fujikawa H; Endo K; Hashimoto A; Tomonaga T; Terachi T; Uchida T
    Int J Urol; 2015 Nov; 22(11):1043-9. PubMed ID: 26251127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal High-intensity Focused Ultrasound Targeted Hemiablation for Unilateral Prostate Cancer: A Prospective Evaluation of Oncologic and Functional Outcomes.
    Feijoo ER; Sivaraman A; Barret E; Sanchez-Salas R; Galiano M; Rozet F; Prapotnich D; Cathala N; Mombet A; Cathelineau X
    Eur Urol; 2016 Feb; 69(2):214-20. PubMed ID: 26164416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
    Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal High Intensity Focused Ultrasound of Unilateral Localized Prostate Cancer: A Prospective Multicentric Hemiablation Study of 111 Patients.
    Rischmann P; Gelet A; Riche B; Villers A; Pasticier G; Bondil P; Jung JL; Bugel H; Petit J; Toledano H; Mallick S; Rouvière O; Rabilloud M; Tonoli-Catez H; Crouzet S
    Eur Urol; 2017 Feb; 71(2):267-273. PubMed ID: 27720531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncologic and Functional Outcomes of Partial Gland Ablation with High Intensity Focused Ultrasound for Localized Prostate Cancer.
    Bass R; Fleshner N; Finelli A; Barkin J; Zhang L; Klotz L
    J Urol; 2019 Jan; 201(1):113-119. PubMed ID: 30036514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer.
    Guillaumier S; Peters M; Arya M; Afzal N; Charman S; Dudderidge T; Hosking-Jervis F; Hindley RG; Lewi H; McCartan N; Moore CM; Nigam R; Ogden C; Persad R; Shah K; van der Meulen J; Virdi J; Winkler M; Emberton M; Ahmed HU
    Eur Urol; 2018 Oct; 74(4):422-429. PubMed ID: 29960750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Intensity Focused Ultrasound Hemigland Ablation for Prostate Cancer: Initial Outcomes of a United States Series.
    Abreu AL; Peretsman S; Iwata A; Shakir A; Iwata T; Brooks J; Tafuri A; Ashrafi A; Park D; Cacciamani GE; Kaneko M; Duddalwar V; Aron M; Palmer S; Gill IS
    J Urol; 2020 Oct; 204(4):741-747. PubMed ID: 32898975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological, Oncologic and Functional Outcomes of a Prospective Registry of Salvage High Intensity Focused Ultrasound Ablation for Radiorecurrent Prostate Cancer.
    Siddiqui KM; Billia M; Arifin A; Li F; Violette P; Chin JL
    J Urol; 2017 Jan; 197(1):97-102. PubMed ID: 27422297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical Trial.
    Chin JL; Billia M; Relle J; Roethke MC; Popeneciu IV; Kuru TH; Hatiboglu G; Mueller-Wolf MB; Motsch J; Romagnoli C; Kassam Z; Harle CC; Hafron J; Nandalur KR; Chronik BA; Burtnyk M; Schlemmer HP; Pahernik S
    Eur Urol; 2016 Sep; 70(3):447-55. PubMed ID: 26777228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncologic and Functional Outcomes of Partial Gland Ablation with High Intensity Focused Ultrasound for Localized Prostate Cancer.
    Bass R; Fleshner N; Finelli A; Barkin J; Zhang L; Klotz L
    J Urol; 2019 Jan; 201(1):113-119. PubMed ID: 30577402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial.
    Ghai S; Finelli A; Corr K; Chan R; Jokhu S; Li X; McCluskey S; Konukhova A; Hlasny E; van der Kwast TH; Incze PF; Zlotta AR; Hamilton RJ; Haider MA; Kucharczyk W; Perlis N
    Radiology; 2021 Mar; 298(3):695-703. PubMed ID: 33529137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-Time MRI-Guided Focused Ultrasound for Focal Therapy of Locally Confined Low-Risk Prostate Cancer: Feasibility and Preliminary Outcomes.
    Ghai S; Louis AS; Van Vliet M; Lindner U; Haider MA; Hlasny E; Spensieri P; Van Der Kwast TH; McCluskey SA; Kucharczyk W; Trachtenberg J
    AJR Am J Roentgenol; 2015 Aug; 205(2):W177-84. PubMed ID: 26204305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal therapy with high-intensity focused ultrasound for prostate cancer: 3-year outcomes from a prospective trial.
    Kaufmann B; Raess E; Schmid FA; Bieri U; Scherer TP; Elleisy M; Donati OF; Rupp NJ; Moch H; Gorin MA; Mortezavi A; Eberli D
    BJU Int; 2024 Apr; 133(4):413-424. PubMed ID: 37897088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.